Efferocytosis, or clearance of apoptotic cells (ACs), by dendritic cells (DCs) leads to immune response suppression and tolerance to self-antigens. However, efferocytosis of infected apoptotic cells (IACs) leads to the production of a mixed pro-and anti-inflammatory cytokine milieu. We examined the DC phenotype and ability to migrate after phagocytosis of ACs or IACs and observed higher levels of CD86 and CCR7 expression in DCs, as well as enhanced migration capacity following efferocytosis of IACs. Interestingly, higher levels of interleukin-1b, interleukin-10 and prostaglandin E 2 (PGE 2 ) were also produced in this context. Blockage of IAC recognition led to an impaired maturation profile and PGE 2 production, which may have contributed to reduced CD86 and CCR7 expression and migration capacity. These data contribute to the understanding of how efferocytosis of sterile or infected cells may regulate the adaptive immune response, although the precise role of PGE 2 in this process requires further investigation.
Introduction
Billions of cells die daily through apoptosis in different tissues during homeostatic processes. Resident macrophages, dendritic cells (DCs) and tissue neighbouring 'non-professional' phagocytes play important roles in the removal of these cells, a process termed efferocytosis. 1, 2 Efficient clearance of apoptotic cells (ACs) depends on important steps described as 'find-me' and 'eat-me' signals. The ACs release different soluble 'find-me' signals such as ATP and the chemokine fractalkine (CX3CL1), hence promoting the recruitment of phagocytes such as macrophages and DCs. 3, 4 Moreover, surface exposure of phosphatidylserine (PS) molecules in ACs is an 'eat me' signal that plays a major role during efferocytosis. 5 The recognition of PS is mediated by several receptors expressed in the cell membrane, such as T-cell immunoglobulin mucin protein 4 and brain angiogenesis inhibitor 1, and this recognition results in the efficient engulfment of ACs. 6, 7 Some reports have shown that efferocytosis may affect innate and adaptive immune responses. For example, during sterile inflammation caused by chemical exposure or cigarette smoke, there is an intense recruitment of Abbreviation: AC, apoptotic cell; BMDC, bone marrow-derived dendritic cells; CCR7, CC-Chemokine receptor type 7; CFSE, carboxyfluorescein succinimidyl ester; COX, cyclooxygenase; DC, dendritic cell; IAC, infected apoptotic cell; IL-10, interleukin-10; LN, lymph node; MFI, median fluorescence intensity; PGE 2 , prostaglandin E 2 ; PS, phosphatidylserine; TGF-b, transforming growth factor-b
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neutrophils and massive accumulation of sterile ACs into the tissue. 8 Efferocytosis of sterile cells induces the production of anti-inflammatory mediators such as interleukin-10 (IL-10), transforming growth factor-b (TGF-b), platelet-activating factor and prostaglandin E 2 (PGE 2 ), which leads to suppression of the immune response. [9] [10] [11] Efferocytosis by macrophages and DCs has been described as an anti-inflammatory and immunosuppressive event involved in tissue remodelling, repair and tolerance. [12] [13] [14] Engulfment of ACs is also related to cross-presentation of antigens and activation of both CD4 + and CD8 + T-cell responses during viral infection 15, 16 and tumour growth. 17, 18 Moreover, during some microbial infections, bacterial products can promote neutrophil death. Phagocytosis of Escherichia coli-infected ACs by DCs results in the production of both pro-and anti-inflammatory mediators, such as TGF-b, IL-6 and IL-23. 19 Although phagocytosis of infected ACs has been characterized as an important innate immunity effector function to impair the proliferation of microorganisms, recent studies have described it as a dangerous process that can promote autoimmunity. 20 Phagocytosis of Mycobacterium tuberculosis-infected ACs by macrophages is involved in the killing of the pathogen, 21, 22 whereas capture of Citrobacter rodentium-infected ACs by DCs leads to bacterial and self-peptide presentation to T cells and the development of autoimmune disorder. 20 In addition to the recognition of ACs, DCs are the most important phagocytes in orchestration of the adaptive immune response. Through a vast repertoire of pattern recognition receptors, DCs recognize and process danger-and pathogen-associated molecular patterns along the endocytic pathway. 23 Then, DCs undergo morphological, phenotypic and functional changes, acquiring an activated status represented by three typical features: (i) high levels of extracellular class II MHC molecules; (ii) increased expression of CD80 and CD86; and (iii) inflammatory mediator production. 24 Moreover, to migrate from the peripheral site to draining lymph nodes (LNs) and initiate a proper adaptive immune response, DCs upregulate CC-Chemokine receptor type 7 (CCR7), which favours migration to LNs in response to chemotactic gradients of CCL19 and/or CCL21. 25 The prostanoid PGE 2 , which is produced during infections, inflammation and efferocytosis, can enhance DC migration to LNs in a CCR7-dependent manner. [26] [27] [28] Contradictory effects of engulfment of ACs on DC maturation have been described. The uptake of apoptotic tumour cells increases CD86 and class II MHC expression as well as migration to LNs. 18 By contrast, efferocytosis of b-pancreatic cells leads to DC immunosuppression caused by PGE 2 production. 12 Given the important role of DCs in the clearance of ACs and the lack of studies comparing the effect of phagocytosis of sterile ACs and E. coliinfected ACs (IACs) on differential migration behaviour and soluble mediator production by DCs, in this study, we evaluated whether phagocytosis of those different sources of ACs promotes differential phenotypes of DC activation. Here, we demonstrate the distinct effects of phagocytosis of ACs or IACs on the maturation and migratory capacity of DCs and on PGE 2 and inflammatory cytokine production.
Materials and methods
Mice C57BL/6 female mice (8-10 weeks old) were purchased from Centro Multidisciplinar para Investigac ßão Biol ogica, Universidade de Campinas (CEMIB/UNICAMP). The animals were maintained in mini-isolators with controlled temperature, humidity, airflow and dark/light cycle with free access to sterilized water and food. BALB/c mice were obtained from the University of São Paulo (USP) at Ribeirão Preto School of Medicine, Brazil. All animal experiments performed were approved by the Institutional Animal Care and Use Committee of the School of Pharmaceutical Sciences, São Paulo State University (UNESP).
Generation of bone-marrow-derived dendritic cells
Dendritic cells were differentiated from bone marrow precursor cells of C57BL/6 mice according to the protocol described by Lutz et al. 29 with a few modifications. Bone-marrow-derived DCs (BMDCs) were cultured in 100 9 20 mm tissue-culture plates (BD Falcon TM ; BD, Franklin Lakes, NJ) with 20 ml of complete RPMI-1640 medium (Lonza, Basel, Switzerland) [supplemented with 10% fetal bovine serum and 10 lg/ml gentamicin (Gibco, Waltham, MA)] containing 40 ng/ml granulocyte-macrophage colony-stimulating factor (PeproTech, Rocky Hill, NJ). On days 3 and 6, the RPMI-1640 medium was replaced with fresh complete RPMI-1640 medium containing 40 ng/ml granulocyte-macrophage colonystimulating factor. On day 7, the supernatant was removed, and the BMDCs were resuspended in RPMI-1640 medium.
Generation of sterile ACs and IACs
As a source of sterile ACs, RAW 264.7 cells cultured in Dulbecco's modified Eagle's medium (Lonza), supplemented with 10% fetal bovine serum were exposed to UVC radiation (0Á35 J) and maintained in a humidified 37°, 5% CO 2 incubator for 4 hr. For IAC generation, RAW 264.7 cells were cultured with E. coli (ATCC 259992) (ratio 1 : 10) for 2 hr for phagocytosis. Then, the cells were washed with PBS (Lonza) to remove the bacteria and cellular debris. The infected cells were exposed to UVC radiation (0Á35 J) and maintained in a humidified 37°, 5% CO 2 incubator, for 4 hr. The ACs and IACs were then collected and resuspended in RPMI-1640 medium, counted and adjusted to the desired cell suspension to perform efferocytosis. Apoptosis was evaluated by staining with Annexin-V conjugated with FITC (FITC Annexin V Apoptosis Detection Kit I, BD Biosciences, USA) following the manufacturer's protocol. Cells were acquired by flow cytometry (FACS Canto, Becton Dickinson, San Diego, CA) (see Supplementary material, Fig. S1b,c) and analysed using the software FCS 4 EXPRESS FLOW CYTOMETRY.
Evaluation of the infected cell rate RAW 264.7 cells were cultured with green fluorescent protein-expressing E. coli (ratio 1 : 10) for 2 hr in Dulbecco's modified Eagle's medium (Lonza) supplemented with 10% fetal bovine serum. To confirm the phagocytosis rate, cells were collected and washed twice with PBS to remove free bacteria and cell debris. Cells were labelled with CD11b, and the percentage of infected cells was confirmed by flow cytometry (see Supplementary material, Fig. S1a ).
Efferocytosis assay
Dendritic cells were co-cultivated with ACs or IACs at a 1 : 3 ratio (DC : AC) in a six-well plate (BD Falcon) with 4 ml of RPMI-1640 serum-free medium supplemented with 10 lg/ml gentamicin. Cells were maintained in a humidified 37°, 5% CO 2 incubator for 13 hr. 
CFSE staining
The carboxyfluorescein succinimidyl ester (CFSE) stock solution was diluted in pre-warmed PBS to a working concentration of 1Á5 lM for the in vitro efferocytosis assay and 2 lM for the in vitro migration assay. Briefly, CFSE at the desired concentration was added to the cells, which were incubated at 37°for 15 min. The cells were centrifuged and resuspended in fresh pre-warmed medium, incubated at 37°for 30 min, and then washed once more, according to the manufacturer's protocol (CellTrace CFSE cell proliferation kit -Life Technologies, NY, USA).
In vitro migration assay
Dendritic cells were isolated by magnetic separation with magnetic CD11c + microbeads (Miltenyi Biotec) according to the manufacturer's protocol. After isolation, the DCs were labelled with CFSE. To evaluate the migration capacity of DCs, 5-lm pore Transwell membranes (Transwell Permeable Supports; Corning Incorporated, Corning, NY) were placed in a 24-well plate, and 2Á5 9 10 5 DCs of each condition in 100 ll of RPMI-1640 serumfree medium were added to the upper chamber. In the lower chamber, 300 ng/ml CCL19 (recombinant murine MIP-3b; PeproTech) and 250 ng/ml CCL21 (recombinant murine exodus-2, PeproTech) chemokines were added in 600 ll of RPMI-1640 serum-free medium. The plate was maintained in a humidified 37°, 5% CO 2 incubator for 6 hr. Then, the transmigrated DCs were photographed. The same fields were imaged using a Nikon Eclipse 50i microscope (Nikon, Melville, NY) with a 109 objective lens. In addition, the transmigrated cells were harvested and counted by flow cytometry.
In vivo migration assay
To perform the in vivo migration assay, DCs differentiated from C57BL/6 bone marrow precursors were labelled with FarRed (1 lM) (CellTrace Far Red Kit; Life Technologies, NY, USA) and then co-cultured with ACs or IACs in a humidified 37°, 5% CO 2 incubator for 13 hr. Then, 2 9 10 6 DCs from each culture were injected into the footpads of BALB/c mice. After 48 hr, cells from popliteal LNs were obtained and analysed by flow cytometry for the presence of IA b+ FarRed + cells.
Evaluation of the DC maturation phenotype
The maturation phenotype of the DCs was assessed using anti mouse-CD11c (BioLegend, San Diego, CA; allophycocyanin-conjugated), anti-mouse-CD197 (CCR7) (BioLegend; phycoerythrin-conjugated), anti-mouse-IA b , (Class II MHC) (BD Pharmingen, San Diego, CA; FITCconjugated) and anti-mouse-CD86 (BioLegend; phycoerythrin/Cy7-conjugated) antibodies by flow cytometry. Non-specific binding was blocked using FcBlock (BD Pharmingen).
RNA extraction and quantitative real-time PCR
RNA was extracted from DCs from each condition and isolated with an RNAspin RNA Isolation Kit (GE Healthcare, Chalfont St Giles, UK) according to the manufacturer's protocol and transcribed into cDNA. For quantitative real-time PCR, an ABI Prim 7300 thermocycler (Applied Biosystems, Foster City, CA) was used. The relative quantity of each sample was normalized to the average level of the constitutively expressed housekeeping gene Gapdh. The following primers were used: Gapdh,
ELISA
To determine the microenvironment created by the DCs under each condition, ELISA was performed to determine the production of IL-6, IL-23, TGF-b, IL-10, IL-1b and PGE 2 . The minimum detectable concentrations were 31Á25 pg/ml for IL-6, IL-1b and IL-10 (BD Pharmingen); 15Á6 pg/ml for TGF-b (DuoSet â ELISA; R&D Systems, Minneapolis, MN); 7Á8 pg/ml for PGE 2 (PGE 2 EIA Kit; Cayman Chemicals, Ann Arbor, MI); and 8 pg/ml for IL-23 (ELISA MAX TM Deluxe Set; Biolegend). All procedures were performed according to the manufacturer's instructions.
Statistical analysis
The results were analysed using PRISM 5.0 (GraphPad Software, San Diego, CA). For comparisons among multiple experimental groups, one-way analysis of variance was performed followed by Tukey's multiple comparison test. For comparisons between two experimental groups, Student's t-test was performed. Statistically significant differences were indicated at P-values of ≤ 0Á05.
Results

Phagocytosis of IACs triggers CD86 and CCR7 up-regulation on DCs
It was previously reported that DCs can migrate and reach peripheral LNs following AC phagocytosis. 30 However, it is still unclear if efferocytosis affects DC maturation and migration in sterile inflammation or infectious microenvironments. Therefore, as a source of sterile and infected ACs, we induced apoptosis in non-infected and E. coli-infected RAW 264.7 cells, respectively. Almost 90% of RAW 264.7 cells were infected with E. coli, and the percentage of early and late apoptosis was approximately 98% (see Supplementary material, Fig. S1b,c) . We then investigated whether the recognition of ACs or IACs distinctly affected the maturation phenotype of DCs. Our results demonstrated that DCs that engulfed ACs showed lower CD86 and CCR7 expression, analogous to unstimulated DCs in resting conditions (Fig. 1a-e) . However, phagocytosis of IACs promoted enhanced expression of CD86 and CCR7 on DCs (Fig. 1a-e) . Indeed, DCs that interacted with IACs showed higher double positivity for CD86 + CCR7 + molecules compared with DCs plus ACs and a phenotype similar to that of DCs incubated with E. coli (Fig. 1a,b) . Regarding MFI analysis, DCs that engulfed IACs presented higher surface expression of CCR7 and CD86 compared with DCs co-cultured with ACs and similar levels compared with DCs incubated in the presence of E. coli (Fig. 1d) .
To confirm that DC maturation was promoted by efferocytosis of IACs carrying pathogen-associated molecular patterns, we blocked efferocytosis using purified Annexin-V microbeads (Ann), which are capable of covering exposed PS, so inhibiting recognition of ACs by phagocytes. Treatment with purified Annexin-V inhibited more than 50% of efferocytosis of IACs (see Supplementary material, Fig. S1d,e) and partially inhibited the expression of CD86 + CCR7 + on DCs (Fig. 1a-d) , suggesting that recognition of IACs by DCs triggers CD86 and CCR7 upregulation. By contrast, recognition of sterile ACs had no effect on the DC phenotype compared with unstimulated DCs in the resting condition.
Efferocytosis of IACs promotes anti-and pro-inflammatory cytokine production
Next, we determined the cytokine environment promoted by the efferocytosis of ACs or IACs. Engulfment of sterile ACs promotes an anti-inflammatory response through the production of IL-10, TGF-b and PGE 2, 10 whereas DC interaction with IACs is followed by production of higher levels of IL-6, TGF-b and IL-23 to create a proper microenvironment for T helper type 17 (Th17) cell differentiation. 19 In addition to IL-6, TGF-b and IL-23, we also observed greater amounts of IL-1b and IL-10 production by DCs co-cultured with IACs compared with DCs co-cultured with sterile ACs (Fig. 2a-e) . Indeed, the blockage of IAC recognition by purified Annexin-V led to lower levels of IL-6 production by DCs (Fig. 2b) . However, the impairment of phagocytosis of IACs by DCs had no effect on TGF-b, IL-23, IL-10 and IL-1b production (Fig. 2a,c-e) .
Phagocytosis of IACs by DCs induces high levels of PGE 2
Macrophages and DCs produce PGE 2 during efferocytosis under homeostatic conditions. data regarding PGE 2 production after the recognition and phagocytosis of IACs. Interestingly, our results demonstrated that recognition of IACs promotes an increase in PGE 2 production of at least 10-fold compared with recognition of ACs by DCs (Fig. 3a) . In contrast, the blockage of PS by Annexin-V microbeads impaired IAC recognition and drastically inhibited PGE 2 production by DCs (Fig. 3a) . Whereas cyclooxygenase 1 (COX-1) is constitutively expressed in almost all cells, COX-2 expression is induced and enhanced during inflammation stimuli. 31 Therefore, we also evaluated whether phagocytosis of ACs and IACs modulated the expression of either COX isoform. Consistent with the increase in PGE 2 production by DCs after each stimulus, COX-2 expression was also enhanced when DCs were co-cultured with E. coli, and its expression was even higher after stimulating DC with IACs (Fig. 3c) . However, when the recognition of IACs was blocked, COX-2 expression and PGE 2 production by DCs decreased (Fig. 3a,c) . By constrast, no significant change in COX-1 expression was observed (Fig. 3b) , suggesting that PGE 2 production during recognition of IACs is probably associated with COX-2 up-regulation.
Efferocytosis of infected cells triggers the maturation and migratory capacity of DCs in vitro and in vivo
As we observed increased CCR7 expression on DCs after efferocytosis, we sought to investigate the capability of DCs to migrate following interaction with ACs or IACs. Phagocytosis of IACs by DCs produced higher amounts of PGE 2 and also improved migration in a CCR7-dependent manner, compared with DCs that engulfed ACs (Figs 3a and 4a,b) . This migratory capacity of DCs was drastically inhibited when efferocytosis of IACs was blocked by Annexin-V microbeads (Fig. 4a,b) . As a proof of concept, we investigated the migration of DCs after efferocytosis of ACs or IACs toward draining LNs in vivo. Bone marrow cells from C57BL/6 mice were differentiated into DCs and labelled with FarRed. These cells were co-cultured with ACs or IACs and injected into the footpads of BALB/c mice. After 48 hr, cells from popliteal LNs were evaluated by IA b+ FarRed + . According to the in vitro results, DCs that engulfed IACs showed enhanced migration toward draining LNs in vivo compared with DCs that phagocytosed ACs (Fig. 4c-e) .
Discussion
Here, we demonstrated differential migration behaviour and soluble mediator production by DCs after efferocytosis of sterile or infected cells. Efferocytosis of infected cells increased CD86 and CCR7 expression on DCs, PGE 2 and IL-6 production, and migration capability. In contrast, phagocytosis of sterile ACs had a low impact on the phenotype and function of DCs. The maturation and migration after recognition of IACs may be related to higher expression of COX-2 and PGE 2 production, as well as a result of pattern recognition receptors activation by bacterial components present inside the endosome.
The presence of DCs in peripheral tissues and their ability to mediate efficient efferocytosis create an opportunity to capture non-self and self antigens during homeostasis or infection. 32 Because DCs can interact with naive T cells through trafficking to LNs, recognition of ACs by DCs may have an important role in T-cell immunity. This event is mainly regulated by the expression of the chemokine receptor CCR7, which promotes migration through lymphatic vessels following a CCL19 and CCL21 chemotactic gradient. 25, 33 Although AC-laden DCs have been found in the draining LNs of many tissues, 30 ,34 here we demonstrated that efferocytosis affects DC activation and migration under sterile and infectious conditions. We found that DCs that recognize either ACs or IACs were able to migrate toward a CCL19/ CCL21 chemokine gradient in vitro as well as toward draining LNs in vivo. However, DCs in the presence of IACs showed greater migration capacity and higher amounts of PGE 2 and IL-6 production compared with the AC condition.
Recent studies have demonstrated that PGE 2 plays an important role in DC migration through CCR7 expression. Hauser et al. demonstrated that PGE 2 alone does not increase CCR7 expression on human monocytederived DCs but induces oligomerization of the CCR7 receptor, leading to an efficient signalling pathway that enhances migration. 27 However, in combination with other mediators such as TNF-a, IL-1b and IL-6, PGE 2 increases CCR7 expression. 28 Our results show that efferocytosis of IACs promotes PGE 2 production, CCR7 expression and migration of DCs. Moreover, efferocytosis blockage caused low PGE 2 production and impaired migration of DCs, demonstrating the importance of efferocytosis to trigger PGE 2 synthesis and favour CCR7 expression and the migration machinery.
The expression of class II MHC, CD86 and CD80 is critical during the activation of naive CD4 + T cells by DCs. 35 Indeed, it has been reported that CD86 plays a greater role in naive CD4 + T-cell activation and differentiation than CD80. 36 Interestingly, we did not observe differences in CD80 and CD40 expression in DCs activated with ACs or IACs (data not shown), whereas interaction with E. coli or E. coli-infected ACs caused enhanced expression of CD86 on DCs. Prostaglandin E 2 is also an important mediator involved in CD86 expression and induction of IL-6 synthesis. 37, 38 Our results support these findings, because the impairment of efferocytosis by blocking PS decreased PGE 2 and IL-6 production and drastically inhibited the migration of DCs in vitro. Therefore, our results suggest that high levels of PGE 2 production during the efferocytosis of IACs could explain the ability of DCs to migrate toward CCL19/CCL21 chemokines and up-regulate CD86 expression.
Phagocytosis of apoptotic tumour cells leads to increased CD86 and class II MHC expression on DCs, and these cells can migrate and present tumour peptides to CD4 + and CD8 + T cells. Indeed, mice vaccinated with DCs plus apoptotic tumour cells developed protective immunity against tumours (melanoma B16). 18 In addition, Bertho et al. 39 have shown greater maturation and migration of DCs after efferocytosis of apoptotic tumour cells and in the presence of exogenous PGE 2 , tumour necrosis factor or lipopolysaccharide. 39 These findings corroborate our results because phagocytosis of IACs promotes high levels of PGE 2 production and induces CD86 and CCR7 expression on DCs. As peptides from ACs can be presented on class I and II MHC molecules, 32, 40, 41 the DC maturation state and production of specific cytokines may promote T-cell subtype commitment. We observed that phagocytosis of ACs promotes IL-10, TGF-b and PGE 2 production. These results corroborate literature data that the recognition of ACs is a silent and antiinflammatory process that is likely to lead to T-cell anergy or regulatory T-cell differentiation. 12, 19, 42 In contrast, the presence of IACs induced elevated IL-6, IL-1b and PGE 2 production, mediators that have been described to be involved in Th17 differentiation. 19 The Th17 cells have been related to host defence against bacterial and fungus infection, as well as in autoimmunity disorders. 43 Hence, considering that DCs phagocytosing IACs acquire the capacity of presenting self and non-self peptides, together with the expression of costimulatory molecules and inflammatory mediators 20 such as PGE 2 , it is important to further address whether the high prevalence of this prostanoid could interfere with Tcell differentiation and actually control Th17 commitment or unwanted self-reactive T-cell clones.
The partial blockage of efferocytosis using Annexin-V microbeads decreased PGE 2 and IL-6 production, whereas synthesis of IL-1b, IL-23, IL-10 and TGF-b was not affected. Since ACs can release soluble mediators such as IL-10 44 and TGF-b, 45 we suggest that some of these cytokines were produced by IACs, which were not engulfed by DCs. Another important point to consider is that accumulated ACs may undergo other types of cell death, such as necrosis or pyroptosis, and release dangerassociated molecular patterns that can activate DCs.
In summary, our results demonstrated that engulfment of IACs was capable of triggering DC migration and upregulation of CD86 and CCR7 molecules. In addition, IAC-activated DCs produced high levels of Th17-related cytokines, as described previously. 19 Moreover, our results demonstrated for the first time that phagocytosis of IACs by DCs induces elevated levels of PGE 2 , probably due to dual activation of pattern recognition receptors that interact with ACs and bacterial components. Given that contradictory findings have indicated that PGE 2 can dampen T-cell activation 46, 47 or improve Th17 differentiation, 48 further investigation is needed to elucidate the role of PGE 2 produced by efferocytosis in triggering T-cell immunity activation, suppression or tolerance.
